AstraZeneca is a Global, Biopharmaceutical Company with Research and Development at its Core. The AstraZeneca Open Innovation platform has been created to identify and establish mutually beneficial collaborations that will lead to the discovery and development of new medicines. It provides a robust but simple process for link their expertise, experience, resources, and technology with those of external experts and to explore prospective partnerships that accelerate the advancement of medical science and breakthrough therapies for patients. And the postdoctoral academic institutions of the selected researchers will receive funding to support the corresponding researches for up to three years.